GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

RBB · Sep 30, 2025

RBB Bancorp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001437749-25-033871Bank
Sequential deposit growth75thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

5.59% · CORE · VALID

Net-income growth80thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

44.99% · CORE · VALID

Interest-income growth45thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

5.45% · CORE · VALID

Cash and equivalents42thOwn-history percentile · N=19
Evidence method

Level · gp.fundamentals.cash

$234.9M · CORE · VALID

Sequential loan growth50thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

3.13% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History34 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.45%
Current
5.59%
Delta
4.14%
Earnings Growth Increased
Previous
28.82%
Current
44.99%
Delta
16.17%
Interest Income Growth Increased
Previous
2.49%
Current
5.45%
Delta
2.96%
Liquidity Increased
Previous
$191.9M
Current
$234.9M
Delta
$43.1M
Loan Growth Increased
Previous
-4.09%
Current
3.13%
Delta
7.21%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.